Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- Revision label updated from v3.4.1 to v3.4.2 on the page. This is a minor frontend/version change that does not affect study details or eligibility criteria.SummaryDifference0.1%

- Check20 days agoChange DetectedSite updated to Revision v3.4.1. The study page content and functionality remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe only visible change is the updated revision tag: Revision: v3.3.4 replacing the previous Revision: v3.3.3 on the Study Documents section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section showing Maryland as a study site; updated the page to revision v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedA clarifying line about publications being provided voluntarily has been added to the Publications section, and a revision tag (v3.3.2) appears, while the previous wording for v3.2.0 was removed.SummaryDifference0.1%

- Check99 days agoChange DetectedRemoved the government funding status notice banner from the page; this banner previously warned that information may not be up to date. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.